First Patient Enrolled in Abiomed's RECOVER IV Randomized Controlled Trial of Impella as a Therapy for AMI Cardiogenic Shock
First trial in AMI cardiogenic shock to use the FDA’s EFIC protocol
Source: dicardiology.com
Chuck Simonton News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Chuck Simonton. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Chuck Simonton Today - Breaking & Trending Today
Abiomed announces enrollment of first patient in landmark RECOVER IV trial for AMI cardiogenic shock
Abiomed, part of Johnson & Johnson MedTech, announces the first patient in the world has been enrolled in the landmark RECOVER IV randomized controlled trial (RCT).
Source: news-medical.net
Valley Hospital makes 'tremendous step forward' in cardiac care
The Valley Hospital in Ridgewood is the first medical institution to use a new technology from Abiomed during a coronary procedure.
Source: njbiz.com
Abiomed reaches new regulatory milestone for its Impella pumps
Abiomed (Nasdaq:ABMD) announced that the FDA accepted and closed its post-approval study reports for its Impella heart pumps.
Source: massdevice.com
U.S. FDA Grants 510(k) Clearance for Impella Low Profile Sheath
Smaller Sheath Simplifies Access and Improves Ease-of-Use
Source: dicardiology.com